Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BioCirc Ringsted Biogas ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.3% 0.3%   Bankruptcy risk   4.5% 1.8% 1.5% 0.8% 1.1% 4.6% 8.6% 8.5%   Credit score (0-100)   48 73 76 90 85 45 29 29   Credit rating   BBB A A A A BBB BB BB   Credit limit (kDKK)   0.0 2.7 37.4 2,198.9 1,233.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   -945 4,874 10,676 16,915 25,278 1,748 0.0 0.0   EBITDA   -945 4,795 10,232 16,058 24,379 -284 0.0 0.0   EBIT   -1,252 1,795 6,868 12,174 20,414 -3,270 0.0 0.0   Pre-tax profit (PTP)   -2,119.6 205.0 4,994.6 11,387.6 19,375.6 -6,077.2 0.0 0.0   Net earnings   -1,769.6 144.4 3,894.5 8,863.9 15,101.9 -4,650.4 0.0 0.0   Pre-tax profit without non-rec. items   -2,120 205 4,995 11,388 19,376 -6,077 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   44,085 56,176 56,123 62,620 66,786 75,859 0.0 0.0   Shareholders equity total   2,766 2,910 6,805 15,669 13,271 8,620 4,120 4,120   Interest-bearing liabilities   17,890 25,203 20,181 24,531 26,412 63,227 0.0 0.0   Balance sheet total (assets)   50,738 63,603 66,187 76,125 77,230 101,735 4,120 4,120   Net Debt   15,883 25,203 20,181 17,850 26,412 56,750 -4,120 -4,120     See the entire balance sheet 1000.0 Volume  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   -945 4,874 10,676 16,915 25,278 1,748 0.0 0.0   Gross profit growth   -5,830.3% 0.0% 119.0% 58.4% 49.4% -93.1% -100.0% 0.0%   Employees   0 0 0 0 3 3 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   50,738 63,603 66,187 76,125 77,230 101,735 4,120 4,120   Balance sheet change%   18,786.1% 25.4% 4.1% 15.0% 1.5% 31.7% -96.0% 0.0%   Added value   -944.7 4,795.0 10,231.8 16,058.1 24,298.5 -284.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   43,696 9,092 -3,417 2,612 201 6,087 -75,859 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -2.0 1.0 2.0 3.0 4.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   132.5% 36.8% 64.3% 72.0% 80.8% -187.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -4.9% 3.1% 10.6% 17.1% 26.6% -3.6% 0.0% 0.0%   ROI %   -6.9% 4.5% 16.1% 26.0% 39.6% -4.9% 0.0% 0.0%   ROE %   -118.2% 5.1% 80.2% 78.9% 104.4% -42.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   5.5% 4.6% 10.3% 20.6% 17.2% 8.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -1,681.3% 525.6% 197.2% 111.2% 108.3% -19,984.2% 0.0% 0.0%   Gearing %   646.8% 866.0% 296.6% 156.6% 199.0% 733.5% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   9.7% 7.4% 8.3% 3.5% 4.1% 6.3% 0.0% 0.0%   1000.0 Liquidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.4 0.6 0.8 1.4 0.4 0.4 0.0 0.0   Current Ratio   0.4 0.7 1.1 1.5 0.5 0.5 0.0 0.0   Cash and cash equivalent   2,006.8 0.0 0.0 6,681.1 0.0 6,477.2 0.0 0.0   1000.0 Capital use efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -9,060.7 -2,871.4 808.8 4,593.3 -9,251.1 -21,549.1 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 8,099 -95 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 8,126 -95 0 0   EBIT / employee   0 0 0 0 6,805 -1,090 0 0   Net earnings / employee   0 0 0 0 5,034 -1,550 0 0